Search research articles
Contact Us
Filters
Showing results (61-70 of 247) with videos related to
Page
of 25
Sort By:
Journal D'Urologie Et De Nephrologie
|
October 1, 1979
[Palliative chemotherapy with 5 FU and CPM in cancer of the prostate with bone metastases resistant to oestrogens. A clinical trial (author's transl)]
R Kuss, S Khoury, F Richard, et al.
La Nouvelle Presse Medicale
|
February 21, 1981
[Results of one year (1978) of kidney transplantation (author's transl)]
P Frantz, J Luciani, C Chatelain, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression
|
April 1, 1983
[Neurologic infectious complications in patients with transplants. Apropos of 8 cases]
M Chauvin, P Mottet, T Mussat, et al.
Mayo Clinic Proceedings
|
October 9, 2003
Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
Sundeep Bhatia, Robert P Frantz, Cathy J Severson, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 24, 2025
A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension
Akshay Kohli, Hilary M DuBrock, Jennifer M Boland, et al.
Human & Experimental Toxicology
|
May 4, 2004
Delayed toxicity following acute ingestion of valpromide
C Payen, P Frantz, O Martin, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 10, 2026
Reply to Montani et al.: Venular remodeling as an Integral Component of CTEPH Rather Than a Distinct Pathology
Akshay Kohli, Hilary M Dubrock, Jennifer M Boland, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2021
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension
Jason H Anderson, Allison K Cabalka, Robert P Frantz, et al.
The American Journal of Physiology
|
December 1, 1993
Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol
T H Fan, R P Frantz, H Elam, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
Portopulmonary hypertension: Results from a 10-year screening algorithm
Michael J Krowka, Karen L Swanson, Robert P Frantz, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 247) with videos related to
Sort By:
Page
of 25
Journal D'Urologie Et De Nephrologie
|
October 1, 1979
[Palliative chemotherapy with 5 FU and CPM in cancer of the prostate with bone metastases resistant to oestrogens. A clinical trial (author's transl)]
R Kuss, S Khoury, F Richard, et al.
La Nouvelle Presse Medicale
|
February 21, 1981
[Results of one year (1978) of kidney transplantation (author's transl)]
P Frantz, J Luciani, C Chatelain, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression
|
April 1, 1983
[Neurologic infectious complications in patients with transplants. Apropos of 8 cases]
M Chauvin, P Mottet, T Mussat, et al.
Mayo Clinic Proceedings
|
October 9, 2003
Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
Sundeep Bhatia, Robert P Frantz, Cathy J Severson, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 24, 2025
A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension
Akshay Kohli, Hilary M DuBrock, Jennifer M Boland, et al.
Human & Experimental Toxicology
|
May 4, 2004
Delayed toxicity following acute ingestion of valpromide
C Payen, P Frantz, O Martin, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 10, 2026
Reply to Montani et al.: Venular remodeling as an Integral Component of CTEPH Rather Than a Distinct Pathology
Akshay Kohli, Hilary M Dubrock, Jennifer M Boland, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2021
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension
Jason H Anderson, Allison K Cabalka, Robert P Frantz, et al.
The American Journal of Physiology
|
December 1, 1993
Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol
T H Fan, R P Frantz, H Elam, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
Portopulmonary hypertension: Results from a 10-year screening algorithm
Michael J Krowka, Karen L Swanson, Robert P Frantz, et al.
Page
of 25